Cancer

  • Urine test may improve bladder cancer diagnosis

    A urine RNA test identified 95 per cent of localised bladder cancers in a study and may help predict response to immunotherapy or chemotherapy. The test analyses RNA messages shed by tumour cells into urine, rather than searching for cancer-related DNA mutations as most blood and urine liquid biopsy tests do. Because RNA reflects which [...]

  • Primary care, research and patient impact: Characterising the real-world burden of CLL

    By Sanius Health Data collected in primary care, through research and from patients at home can help build a better understanding of disease, patient experience and opportunities to improve outcomes. What has become increasingly clear is that some of the most important information about a patient is not always captured during a hospital appointment. For [...]

  • AI tool aims to cut radiotherapy treatment delays

    GE HealthCare and Mass General Brigham are building a generative AI tool to help radiotherapy teams navigate fragmented patient data and speed up treatment.

  • AI model predicts pancreatic cancer risk 3 years before diagnosis

    An AI model predicted pancreatic cancer risk up to three years before diagnosis using routine health records from nearly 40,000 patients. The model analysed health histories collected over time alongside routine laboratory test results spanning an average of a decade or more. Researchers found it could distinguish between people at higher and lower risk of [...]

  • AI tool could tailor breast cancer screening for women according to individual risk

    An AI model using multiple years of 3D mammograms predicted five-year breast cancer risk more accurately than models using a single 3D or 2D scan. The deep-learning tool, called NYU-DRP, analyses mammograms taken over several years to assess changes in breast tissue between screenings. It correctly ranked women at higher risk 72 per cent of [...]

  • At-home urine test detects 92% of bladder cancer cases in NHS trial

    The results suggest the test could help identify patients at greater risk of bladder cancer who may need to be prioritised for urgent cystoscopy. Researchers hope it could reduce the number of patients requiring urgent cystoscopies, invasive procedures in which a small camera is inserted through the urethra into the bladder. The study was led [...]

  • London surgeons perform world-first AI-assisted brain tumour surgery

    London surgeons have performed what health officials described as the first successful AI-assisted brain tumour operation, helping save a patient's sight. The surgery was carried out in May on 48-year-old Rhys Hibbert, who had an 11mm tumour on his pituitary gland and faced losing his sight without an operation, health officials said. During the procedure, [...]

  • The two cancer survivors turning a turmeric compound into a £10m business

    KURK didn’t begin as a business. It began as a lifeline. In a pharmaceutical-grade lab in Twickenham, the company is transforming how the body absorbs curcumin, the anti-inflammatory compound found in turmeric. Founded by lymphoma survivors Prof Dr Harrison “Harry” Weisinger and Trent Scanlen, the biotech company spent six years developing a micelle-based delivery system [...]

  • Personalised vaccine stops cancer returning in trial

    A personalised melanoma vaccine has extended cancer-free time in high-risk patients when combined with Keytruda, according to interim trial results. The phase three trial involved more than 1,000 patients with high-risk stage two, three or four melanoma who had undergone surgery. Early results indicate that combining the vaccine with Keytruda significantly increased the time patients [...]

  • Clinic offers blood test that screens for more than 50 cancers

    A Leicester clinic is offering a new blood test which screens for a signal shared by more than 50 types of cancer. The Health Suite, a private doctor-led medical and wellness centre, is one of the first private healthcare providers in the UK to offer the Galleri blood test following the publication of initial results [...]